TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Essex Bio-Technology ( (HK:1061) ).
Essex Bio-Technology Limited announced an interim dividend of HKD 0.07 per share for the six months ending June 30, 2025. This announcement reflects the company’s financial performance and commitment to returning value to shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (HK:1061) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Essex Bio-Technology stock, see the HK:1061 Stock Forecast page.
More about Essex Bio-Technology
Essex Bio-Technology Limited operates in the biotechnology industry, focusing on the development and commercialization of biopharmaceutical products. The company primarily offers products related to ophthalmology and dermatology, targeting markets that require advanced therapeutic solutions.
Average Trading Volume: 1,622,752
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.28B
Learn more about 1061 stock on TipRanks’ Stock Analysis page.